Comprehensive literature review: Recent advances in diagnosing and managing patients with poorly differentiated thyroid carcinoma

International Journal of Endocrinology

Volumn 2013, Issue , 2013, Pages

  Hannallah, Jack ^a   Rose, Jessica ^a   Guerrero, Marlon A ^a,b  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; B RAF KINASE; BETA CATENIN; IODINE 131; KI 67 ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE; MOTESANIB; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN P53; PROTEIN PATCHED; PROTEIN RET; RAS PROTEIN; SORAFENIB; SUNITINIB; TRANSCRIPTION FACTOR PAX8; UVOMORULIN; VANDETANIB;

ANAPLASTIC THYROID CANCER; BRAF GENE; CANCER SURVIVAL; CHEMORADIOTHERAPY; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIATED THYROID CANCER; EXTERNAL BEAM RADIOTHERAPY; FINE NEEDLE ASPIRATION BIOPSY; GENE MUTATION; GENE REARRANGEMENT; GENETIC SCREENING; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; ONCOGENE RAS; PAX8 GENE; POORLY DIFFERENTIATED THYROID CANCER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PTC GENE; RET GENE; REVIEW; SUBTOTAL THYROIDECTOMY; SURVIVAL RATE; THYROID CARCINOMA; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA; THYROID SURGERY; TUMOR ABLATION; TUMOR DIFFERENTIATION; TUMOR SUPPRESSOR GENE;

EID: 84874850023     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2013/317487     Document Type: Review

References (31)

1. Robbins S. L., Kumar V., Abbas A. K., Cotran R. S., Fausto N., Robbins and Cotran Pathologic Basis of Disease 2010 Philadelphia, Pa, USA WB Saunders
2. Sanders E. M. Jr., LiVolsi V. A., Brierley J., Shin J., Randolph G. W., An evidence-based review of poorly differentiated thyroid cancer. World Journal of Surgery 2007 31 5 934 945 2-s2.0-34248232601 10.1007/s00268-007-9033-3 (Pubitemid 46716789)
3. Volante M., Collini P., Nikiforov Y. E., Sakamoto A., Kakudo K., Katoh R., Lloyd R. V., LiVolsi V. A., Papotti M., Sobrinho-Simoes M., Bussolati G., Rosai J., Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach. American Journal of Surgical Pathology 2007 31 8 1256 1264 2-s2.0-34248177447 10.1097/PAS.0b013e3180309e6a (Pubitemid 47207131)
4. Volante M., Landolfi S., Chiusa L., Palestini N., Motta M., Codegone A., Torchio B., Papotti M. G., Poorly differentiated carcinomas of the thyroid with trabecular, insular, and solid patterns: a clinicopathologic study of 183 patients. Cancer 2004 100 5 950 957 2-s2.0-1242314234 10.1002/cncr.20087 (Pubitemid 38222855)
5. Sakamoto A., Kasai N., Sugano H., Poorly differentiated carcinoma of the thyroid. A clinicopathologic entity for a high-risk group of papillary and follicular carcinomas. Cancer 1983 52 10 1849 1855 2-s2.0-0021055244 (Pubitemid 14228153)
6. Carcangiu M. L., Zampi G., Rosai J., Poorly differentiated ("insular") thyroid carcinoma. A reinterpretation of Langhans' 'Wuchernde Struma'. American Journal of Surgical Pathology 1984 8 9 655 668 2-s2.0-0021165886 (Pubitemid 14068779)
7. Hiltzik D., Carlson D. L., Tuttle R. M., Chuai S., Ishill N., Shaha A., Shah J. P., Singh B., Ghossein R. A., Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients. Cancer 2006 106 6 1286 1295 2-s2.0-33644843087 10.1002/cncr.21739 (Pubitemid 43363905)
8. Bongiovanni M., Sadow P. M., Faquin W. C., Poorly differentiated thyroid carcinoma: a cytologic-histologic review. Advances in Anatomic Pathology 2009 16 5 283 289 2-s2.0-69349085566 10.1097/PAP.0b013e3181b50640
9. Bongiovanni M., Faquin W. C., Poorly differentiated thyroid carcinoma. The Bethesda System For Reporting Thyroid Cytopathology 2010 New York, NY, USA Springer 129 138 10.1007/978-0-387-87666-5-10
10. Garcia-Rostan G., Sobrinho-Simões M., Poorly differentiated thyroid carcinoma: an evolving entity. Diagnostic Histopathology 2011 17 3 114 123 2-s2.0-79952123602 10.1016/j.mpdhp.2010.12.001
11. Carcangiu M. L., Zampi G., Pupi A., Papillary carcinoma of the thyroid. A clinicopathologic study of 241 cases treated at the University of Florence, Italy. Cancer 1985 55 4 805 828 2-s2.0-0021984674 (Pubitemid 15173519)
12. Soares P., Lima J., Preto A., Castro P., Vinagre J., Celestino R., Genetic alterations in poorly differentiated and undifferentiated thyroid carcinomas. Current Genomics 2011 12 8 609 617 10.2174/138920211798120853
13. Bongiovanni M., Bloom L., Krane J. F., Baloch Z. W., Powers C. N., Hintermann S., Pache J. C., Faquin W. C., Cytomorphologic features of poorly differentiated thyroid carcinoma: a multi-institutional analysis of 40 cases. Cancer Cytopathology 2009 117 3 185 194 2-s2.0-69349088553 10.1002/cncy.20023
14. Patel K. N., Shaha A. R., Poorly differentiated and anaplastic thyroid cancer. Cancer Control 2006 13 2 119 128 2-s2.0-33745199172
15. Pulcrano M., Boukheris H., Talbot M., Caillou B., Dupuy C., Virion A., De Vathaire F., Schlumberger M., Poorly differentiated follicular thyroid carcinoma: prognostic factors and relevance of histological classification. Thyroid 2007 17 7 639 646 2-s2.0-34548163797 10.1089/thy.2007.0029 (Pubitemid 47311553)
16. Nikiforov Y., Biddinger P. W., Thompson L. D., Diagnostic Pathology and Molecular Genetics of the Thyroid 2009 Philadelphia, Pa, USA Lippincott Williams & Wilkins
17. Rocha A. S., Soares P., Fonseca E., Cameselle-Teijeiro J., Oliveira M. C., Sobrinho-Simões M., E-cadherin loss rather than β -catenin alterations is a common feature of poorly differentiated thyroid carcinomas. Histopathology 2003 42 6 580 587 10.1046/j.1365-2559.2003.01642.x (Pubitemid 36688152)
18. Nikiforov Y. E., Thyroid carcinoma: molecular pathways and therapeutic targets. Modern Pathology 2008 21 2 S37 S43 2-s2.0-42549088683 10.1038/modpathol.2008.10 (Pubitemid 351592770)
19. Walczyk A., Kowalska A., Sygut J., The clinical course of poorly differentiated thyroid carcinoma (insular carcinoma)-own observations. Endokrynologia Polska 2010 61 5 467 473 2-s2.0-78650033894
20. Hunt J. L., LiVolsi V. A., Poorly differentiated and undifferentiated thyroid carcinomas. Molecular Pathology of Endocrine Diseases 2010 3 New York, NY, USA Springer 95 101 10.1007/978-1-4419-1707-2-10
21. Asioli S., Erickson L. A., Righi A., Jin L., Volante M., Jenkins S., Papotti M., Bussolati G., Lloyd R. V., Poorly differentiated carcinoma of the thyroid: validation of the Turin proposal and analysis of IMP3 expression. Modern Pathology 2010 23 9 1269 1278 2-s2.0-77956294580 10.1038/modpathol.2010. 117
22. Nikiforova M. N., E Nikiforov Y., Molecular genetics of thyroid cancer: implications for diagnosis, treatment and prognosis. Expert Review of Molecular Diagnostics 2008 8 1 83 95 2-s2.0-38149036597 10.1586/14737159.8.1.83
23. Sobrinho-Simões M., Máximo V., Rocha A. S., Trovisco V., Castro P., Preto A., Lima J., Soares P., Intragenic mutations in thyroid cancer. Endocrinology & Metabolism Clinics of North America 2008 37 2 333 362 2-s2.0-43849083525 10.1016/j.ecl.2008.02.004 (Pubitemid 351698087)
24. Nikiforov Y. E., Genetic alterations involved in the transition from well-differentiated to poorly differentiated and anaplastic thyroid carcinomas. Endocrine Pathology 2004 15 4 319 327 2-s2.0-13444311710 10.1385/EP:15:4:319 (Pubitemid 40208912)
25. Chao T. C., Lin J. D., Chen M. F., Insular carcinoma: infrequent subtype of thyroid cancer with aggressive clinical course. World Journal of Surgery 2004 28 4 393 396 2-s2.0-1942444357 10.1007/s00268-003-7264-5 (Pubitemid 38525874)
26. Jung T. S., Kim T. Y., Kim K. W., Oh Y. L., Park D. J., Cho B. Y., Shong Y. K., Kim W. B., Park Y. J., Jung J. H., Chung J. H., Clinical features and prognostic factors for survival in patients with poorly differentiated thyroid carcinoma and comparison to the patients with the aggressive variants of papillary thyroid carcinoma. Endocrine Journal 2007 54 2 265 274 2-s2.0-34249095533 10.1507/endocrj.K06-166 (Pubitemid 46798649)
27. Randolph G. W., Kamani D., The importance of preoperative laryngoscopy in patients undergoing thyroidectomy: voice, vocal cord function, and the preoperative detection of invasive thyroid malignancy. Surgery 2006 139 3 357 362 2-s2.0-33644993916 10.1016/j.surg.2005.08.009
28. The American Joint Committee on Cancer (AJCC), TNM Classification to Define Thyroid Cancer
29. Grande E., Díez J. J., Zafon C., Capdevila J., Thyroid cancer: molecular aspects and new therapeutic strategies. Journal of Thyroid Research 2012 2012 10 847108 10.1155/2012/847108
30. Wang W., Larson S. M., Fazzari M., Tickoo S. K., Kolbert K., Sgouros G., Yeung H., Macapinlac H., Rosai J., Robbins R. J., Prognostic value of [18F] fluorodeoxyglucose positron emission tomographic scanning in patients with thyroid cancer. Journal of Clinical Endocrinology and Metabolism 2000 85 3 1107 1113 2-s2.0-0034335410 10.1210/jc.85.3.1107 (Pubitemid 32269357)
31. Ito Y., Hirokawa M., Higashiyama T., Takamura Y., Miya A., Kobayashi K., Matsuzuka F., Kuma K., Miyauchi A., Prognosis and prognostic factors of follicular carcinoma in Japan: importance of postoperative pathological examination. World Journal of Surgery 2007 31 7 1417 1424 2-s2.0-34250687538 10.1007/s00268-007-9095-2 (Pubitemid 46945384)